Pulmonary metastases and bleeding in the anticoagulated oncology patient with thrombosis: is the risk solely influenced by the location of distant disease?

The article by García-García V et al. [1], published in this issue of the European Journal of Internal Medicine,provides a valuable exploration of hemorrhagic complications in cancer-associated thrombosis, addressing a critical yet underexplored aspect of patient management. However, certain methodological aspects merit further discussion to strengthen the study's rigor and clinical relevance.